BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chevaliez S, Onelia F, Pacenti M, Goldstein E, Galán JC, Martínez-García L, Vilas A, Glass A, Maree L, Krügel M, Ehret R, Knechten H, Braun P, Naeth G, Bonanzinga S, Jackson K, Abravaya K, Dhein J, Huang S, Joseph AM, Lucic D, Marlowe N, Palm MJ, Pfeifer K, Toolsie D, Reinhardt B, Obermeier M, Gunson R. Multicenter clinical evaluation of alinity m HCV assay performance. J Clin Virol 2020;129:104531. [PMID: 32688330 DOI: 10.1016/j.jcv.2020.104531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Perchetti GA, Pepper G, Shrestha L, LaTurner K, Yae Kim D, Huang ML, Jerome KR, Greninger AL. Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay. J Clin Virol 2021;140:104869. [PMID: 34023572 DOI: 10.1016/j.jcv.2021.104869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Garrigou O, Ortonne V, Soulier A, Chevaliez S. Dried blood spot sampling for hepatitis C virus infection: A new tool to simplify testing algorithms. J Clin Virol 2021;141:104876. [PMID: 34126544 DOI: 10.1016/j.jcv.2021.104876] [Reference Citation Analysis]
3 Galindo LT, Hristov AD, Gentil LG, Scarpelli L, Santiago J, Levi JE. Performance evaluation of the fully automated molecular system Alinity m in a high-throughput central laboratory. Journal of Clinical Virology 2021;137:104786. [DOI: 10.1016/j.jcv.2021.104786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Obermeier M, Pacenti M, Ehret R, Onelia F, Gunson R, Goldstein E, Chevaliez S, Vilas A, Glass A, Maree L, Krügel M, Knechten H, Braun P, Naeth G, Azzato F, Lucic D, Marlowe N, Palm MJ, Pfeifer K, Reinhardt B, Dhein J, Joseph AM, Martínez-garcía L, Galán J. Improved molecular laboratory productivity by consolidation of testing on the new random-access analyzer Alinity m. Journal of Laboratory Medicine 2020;44:319-28. [DOI: 10.1515/labmed-2020-0102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
5 Kogoj R, Kmetič P, Oštrbenk Valenčak A, Fujs Komloš K, Seme K, Sagadin M, Korva M, Poljak M. Real-Life Head-to-Head Comparison of Performance of Two High-Throughput Automated Assays for the Detection of SARS-CoV-2 RNA in Nasopharyngeal Swabs: The Alinity m and cobas 6800 SARS-CoV-2 Assays. J Mol Diagn 2021;23:920-8. [PMID: 34020039 DOI: 10.1016/j.jmoldx.2021.05.003] [Reference Citation Analysis]
6 Ortonne V, Wlassow M, Hézode C, François M, Rosa I, Pawlotsky JM, Chevaliez S. Diagnosis and monitoring of hepatitis C virus infection using the cobas® HCV test for use on the cobas® 4800 system. J Clin Virol 2021;141:104873. [PMID: 34111663 DOI: 10.1016/j.jcv.2021.104873] [Reference Citation Analysis]
7 Murayama A, Momose H, Yamada N, Matsubayashi K, Muramatsu M, Hamaguchi I, Kato T. Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection. Front Cell Infect Microbiol 2022;11:793472. [DOI: 10.3389/fcimb.2021.793472] [Reference Citation Analysis]